HECTOR: A Web-Based Tool for Automated BRCA1/BRCA2 Variant Classification Under the ClinGen ENIGMA Specifications

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background

The ClinGen ENIGMA BRCA1 / BRCA2 Variant Curation Expert Panel (VCEP) has adapted the American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) framework into gene-specific specifications. However, applying these specifications manually remains labor-intensive and prone to inconsistency, requiring integration of population, computational, functional, and clinical evidence through gene-specific decision trees and a points-based classification system.

Methods

We developed HECTOR (HEreditary Cancer varianT Online Reclassifier), a free web-based tool that implements the complete ENIGMA VCEP v1.2 specifications for BRCA1 and BRCA2 . HECTOR automatically populates all evidence codes derivable from public data, routes curator-dependent evidence to a manual input layer and returns a transparent five-tier classification with code-level evidence. We validated HECTOR against two independent reference datasets: the 143-variant ENIGMA Evidence Repository, used as a clinical-grade reference standard, and 134 manually curated in-house variants of uncertain significance (132 unique variants). HECTOR was then applied to the complete ClinVar BRCA1 / BRCA2 catalog (n = 34,077).

Results

At the criterion level, HECTOR exactly reproduced 326 of 413 VCEP-assigned criteria (78.9%), with discordance arising predominantly from curator-dependent evidence rather than implementation errors. In an independent cohort of 134 manually curated in-house variants, HECTOR was fully concordant with expert consensus at the classification level and, even without auto-populated likelihood-ratio evidence, resolved more variants to a definitive classification than two generic ACMG/AMP classifiers. Across ClinVar, HECTOR classified 33,913 variants. Agreement with definitive ClinVar classifications was 96.7% for pathogenic variants and %72.7 for benign variants overall. Among variants for which HECTOR generated a definitive classification, directional concordance reached 99.7% for pathogenic and 99.9% for benign variants. HECTOR also resolved a substantial proportion of variants classified as uncertain (67.3%) or conflicting (88.7%), predominantly toward benign classifications.

Conclusions

HECTOR provides a faithful, transparent implementation of the ENIGMA VCEP v1.2 specifications for BRCA1 and BRCA2 , enabling rapid, standardized, and reproducible application of gene-specific variant classification guidelines while reducing the burden of manual curation.

Article activity feed